Skip to main content

Table 3 Proportional hazards model to identify independent predictors of survival and to compare hepatocellular carcinoma patient data in this study to the data of patients in the original SNACOR study [7]

From: Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma

 

SNACOR parameters

Hazard ratio (95% CI)

P-value

This study

Tumour size

≥5 cm vs. < 5 cm

2.51 (1.88–3.36)

< 0.001

Tumour number

≥4 vs. < 4

1.28 (0.93–1.75)

0.127

Baseline AFP level

≥400 ng/ml vs. < 400 ng/ml

1.76 (1.28–2.43)

< 0.001

Child-Pugh class

A vs. B

1.56 (1.16–2.12)

0.004

Objective radiological response

CR + PR vs. SD + PD

0.97 (0.73–1.28)

0.821

Original SNACOR study

Tumour size

≥5 cm vs. < 5 cm

1.29 (0.95–0.17)

0.100

Tumour number

≥4 vs. < 4

1.68 (1.24–2.28)

0.001

Baseline AFP level

≥400 ng/ml vs. < 400 ng/ml

2.09 (1.55–2.82)

< 0.001

Child-Pugh class

A vs. B

1.44 (0.96–2.14)

0.074

Objective radiological response

CR + PR vs. SD + PD

2.24 (1.65–3.03)

< 0.001